Scarica l'app Stockscreener
210.98
0.15%
-0.31
Dopo l'orario di chiusura:
210.98
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$211.29
Aprire:
$210.81
Volume 24 ore:
439.81K
Relative Volume:
0.40
Capitalizzazione di mercato:
$15.41B
Reddito:
$2.88B
Utile/perdita netta:
$499.60M
Rapporto P/E:
31.30
EPS:
6.74
Flusso di cassa netto:
$321.60M
1 W Prestazione:
-2.38%
1M Prestazione:
+3.82%
6M Prestazione:
-34.78%
1 anno Prestazione:
-42.20%
Intervallo 1D:
$209.81
$213.34
Intervallo di 1 settimana:
$206.13
$217.59
Portata 52W:
$187.43
$372.52
West Pharmaceutical Services Inc Stock (WST) Company Profile
Nome
West Pharmaceutical Services Inc
Settore
Industria
Telefono
(610) 594-2900
Indirizzo
530 HERMAN O. WEST DRIVE, EXTON, PA
Confronta WST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
210.98 | 15.41B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
531.82 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
167.00 | 58.65B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
97.38 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
240.66 | 35.34B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.57 | 16.25B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Iniziato | Citigroup | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-12 | Aggiornamento | UBS | Neutral → Buy |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-11-30 | Iniziato | UBS | Neutral |
| 2022-10-28 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Iniziato | Stephens | Equal-Weight |
| 2020-07-21 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-04-24 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Downgrade | Jefferies | Buy → Hold |
| 2019-04-23 | Iniziato | William Blair | Outperform |
| 2018-04-25 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2017-10-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Iniziato | Stephens | Equal-Weight |
| 2017-09-15 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-10-28 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Iniziato | Wells Fargo | Outperform |
| 2010-05-14 | Reiterato | UBS | Neutral |
| 2010-02-23 | Iniziato | Jefferies & Co | Buy |
| 2008-12-19 | Iniziato | UBS | Neutral |
Mostra tutto
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives - Business Wire
West Pharmaceutical Services: Will Its SmartDose Technology Development Enhance The Business Segment's Competitive Positioning? - Smartkarma
Is West Pharmaceutical Services, Inc (WST) positioned for future growth? - Sete News
West Pharmaceutical Services (WST) Fell on Disappointing Guidance - Insider Monkey
Press Release Distribution & PR Platform - ACCESS Newswire
Here’s Why West Pharmaceutical Services (WST) Stock Fell 38% - Insider Monkey
The Best Healthcare Stocks to Buy - Morningstar
BlackRock, Inc. Reduces Stake in West Pharmaceutical Services Inc. - GuruFocus
West Pharmaceutical Services, Inc. (WST): Among the Worst Performing Stocks in S&P 500 So Far in 2025 - Insider Monkey
Market Update: West Pharmaceutical Services, Inc (WST) Sees Negative Movement, Closing at 213.46 - DWinneX
West Pharmaceutical Services First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
It Looks Like West Pharmaceutical Services, Inc.'s (NYSE:WST) CEO May Expect Their Salary To Be Put Under The Microscope - simplywall.st
The Potential Rise in the Price of West Pharmaceutical Services, Inc (WST) following insiders activity - knoxdaily.com
West Pharmaceutical Services Earnings: What To Look For From WST - MSN
Exton’s West Pharmaceuticals Braces for $25 Million Tariff Bite - VISTA.Today
Ex-Dividend Reminder: West Pharmaceutical Services, Agree Realty and Citizens Financial Group - Nasdaq
What is William Blair’s Estimate for WST Q3 Earnings? - Defense World
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript - MSN
West pharmaceutical increases FY 2025 revenue guidance to $2.975B - MSN
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWO - GuruFocus
West Pharmaceutical Services and Philadelphia Eagles Partner for Earth Day Initiative - MSN
West Pharmaceutical Services Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks
West Pharmaceutical Services, Inc [WST] Shares Fall Approximately -43.90% Over the Year - knoxdaily.com
Jefferies & Co Adjusts West Pharmaceutical Services Price Target to $245 From $240, Maintains Buy Rating - marketscreener.com
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit - MSN
West Pharmaceutical: Q1 Earnings Snapshot - Huron Daily Tribune
West Pharmaceutical Services Reports Q1 2025 Earnings - TipRanks
West Pharmaceutical Q1 2025 slides: Sales edge up while EPS declines By Investing.com - Investing.com South Africa
West Pharmaceutical Services (WST) Raises 2025 Outlook Following Strong Q1 Results - GuruFocus
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag - Benzinga
West Pharmaceutical Q1 2025 slides: Sales edge up while EPS declines - Investing.com India
West Pharmaceutical Services, Inc: Weathering Stock Market Storms with 15.33B Market Cap - investchronicle.com
West Pharmaceutical Q1 2025 Earnings Preview - MSN
West Pharmaceutical Services expects to take at least a $20M hit from Trump tariffs - The Business Journals
West Pharma falls as it expects lower growth from drug components business - TradingView
Earnings call transcript: West Pharmaceutical Q1 2025 earnings beat forecasts - Investing.com
West Pharmaceutical CFO Bernard Birkett to Retire - marketscreener.com
West Pharma raises profit forecast as dollar weakens amid Trump’s tariff policies - 1330 & 101.5 WHBL
West Pharmaceutical Services beats Q1 estimates, raises guidance By Investing.com - Investing.com Canada
West Pharmaceutical Services Reports Q1 2025 Financial Results - TipRanks
West Pharmaceutical Announces Leadership Changes Amid Succession Planning - TipRanks
West Pharmaceutical Services beats Q1 estimates, raises guidance - Investing.com Australia
West Pharmaceutical Services Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits - Quantisnow
West Pharmaceutical Services, Inc. Announces Management Changes - marketscreener.com
West Pharmaceutical Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies - Reuters
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
WEST PHARMACEUTICAL SVSC Earnings Results: $WST Reports Quarterly Earnings - Nasdaq
West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):